VIPR1 and Obesity: Another study from Lijnen et al. [97] described that a treatment with monoclonal antibodies to inhibit VPAC1 in WT mice, fed a high-fat diet to induce obesity for 15 weeks, failed to suppress the increase in body weight and fat mass; however, it determined subcutaneous adipocyte hypertrophy.